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ABSTRACT
Intramammary infection (IMI) is one of the most 
costly diseases to the dairy industry. It is primarily 
due to bacterial infection and the major intramammary 
pathogens include Escherichia coli, Streptococcus uberis, 
and Staphylococcus aureus. The severity and outcome 
of IMI is dependent on several host factors including 
innate host resistance, energy balance, immune status, 
parity, and stage of lactation. Additionally, the infect-
ing organism can influence the host immune response 
and progression of disease. It is increasingly recognized 
that not only the infecting pathogen species, but also 
the strain, can affect the transmission, severity, and 
outcome of IMI. For each of 3 major IMI-associated 
pathogens, S. aureus, Strep. uberis, and E. coli, specific 
strains have been identified that are adapted to the in-
tramammary environment. Strain-dependent variation 
in the host immune response to infection has also been 
reported. The diversity of strains associated with IMI 
must be considered if vaccines effective against the full 
repertoire of mammary pathogenic strains are to be de-
veloped. Although important advances have been made 
recently in understanding the molecular mechanism 
underpinning strain-specific virulence, further research 
is required to fully elucidate the cellular and molecu-
lar pathogenesis of mammary adapted strains and the 
role of the strain in influencing the pathophysiology of 
infection. Improved understanding of molecular patho-
genesis of strains associated with bovine IMI will con-
tribute to the development of new control strategies, 
therapies, and vaccines. The development of enabling 
technologies such as pathogenomics, transcriptomics, 
and proteomics can facilitate system-level studies of 
strain-specific molecular pathogenesis and the identifi-
cation of key mediators of host-pathogen interactions.
Key words: intramammary infection, strain, mastitis 
pathogens
INTRODUCTION
Bovine mastitis, inflammation of the mammary 
gland, is a disease of substantial economic importance. 
The major cause of mastitis is IMI by a bacterium, and 
although a wide variety of species have been associated 
with IMI, several pathogens, including Staphylococcus 
aureus, Streptococcus uberis, Escherichia coli, and CNS, 
account for the majority of cases (Bradley et al., 2007; 
Petrovski et al., 2011; Keane et al., 2013). The preva-
lence of these major IMI-associated pathogens varies 
from region to region. In the United States and United 
Kingdom, E. coli and Strep. uberis have been reported 
as the species most commonly associated with clinical 
IMI (Bradley et al., 2007; Hertl et al., 2014), whereas 
in the pasture-based production systems of Ireland and 
New Zealand, S. aureus and Strep. uberis predominate 
(Petrovski et al., 2011; Keane et al., 2013).
The costs associated with mastitis result from re-
duced milk yield and quality, discarded milk, veterinary 
and treatment costs, culling of chronically infected ani-
mals, and increased labor. It is difficult to accurately 
estimate the cost of bovine mastitis globally, but it has 
been reported that in Ireland an increase in the bulk 
milk SCC from <100,000 cells/mL to 300,000–400,000 
cells/mL decreased net farm profit from €0.059/kg to 
€0.033/kg (Geary et al., 2012). In the United States it 
was reported that the average cost of a mastitis case 
was $325.75 for first lactation heifers and $426.50 in 
later lactations (Liang et al., 2017), whereas in the 
Netherlands the total economic losses associated with 
clinical and subclinical mastitis were estimated to be 
€114 to €182 per cow per year (Huijps et al., 2008). 
In addition to the economic impact, mastitis can have 
serious negative consequences for animal health and 
welfare.
Intramammary infections can present as clinical or 
subclinical. Clinical mastitis is associated with visible 
changes in the milk or udder (flakes or clots in the milk, 
redness, swelling, or hardness in the udder) whereas the 
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more common subclinical mastitis is characterized by 
changes in some parameter of the milk; a rise in SCC 
above 200,000 cells/mL or an increase in the activity 
of N-acetyl-β-d-glucosaminidase can indicate that an 
infection has occurred (Bradley, 2002; Hovinen et al., 
2016). The major mastitis-causing pathogen species are 
commonly associated with different courses of infec-
tion, although the relationship is not absolute. Esch-
erichia coli is often associated with rapid onset, acute 
mastitis with severe symptoms. In many cases the 
infection is self-resolving without the need for veteri-
nary intervention; however, it can occasionally lead to 
systemic infection and death (Zadoks and Fitzpatrick, 
2009). In contrast, infection with S. aureus is usually 
less severe but frequently results in a chronic infection 
that is difficult to eradicate. It may also present with 
occasional clinical flare-ups (Wellnitz and Bruckmaier, 
2012). Streptococcus uberis is regularly associated with 
subclinical IMI, which in some instances can persist 
in the intramammary environment; however, clinical 
Strep. uberis infection also occurs (Zadoks et al., 2003; 
Bannerman et al., 2004a).
Mastitis pathogens have historically been classified 
as contagious or environmental based on their primary 
reservoir and mode of transmission (Bradley, 2002). 
The prevalence of IMI in a herd is dependent on the 
rate at which new infections arise and the length of 
those infections (Wilson et al., 1997). These in turn are 
influenced by a variety of factors such as parity, stage 
of lactation, the nature of the infectious agent, and the 
nutrition and environment of the cow (Smith et al., 
1984; Hertl et al., 2011; Elghafghuf et al., 2014; Moyes, 
2015). Although contagious pathogens are transmitted 
from cow to cow, usually at milking, environmental 
pathogens, with a reservoir in the cow’s environment, 
often infect opportunistically. The major contagious 
pathogens were traditionally considered to be Strepto-
coccus agalactiae and S. aureus with E. coli and Strep. 
uberis considered environmental pathogens (Bradley, 
2002). More recently it has been recognized that some 
IMI pathogens may be capable of both contagious and 
environmental transmission and that the mode of trans-
mission may be associated with the strain rather than 
species of pathogen (Zadoks et al., 2000; Budd et al., 
2015; Davies et al., 2016). Prevention and management 
of contagious mastitis relies on the implementation of 
several well-characterized infection control strategies 
such as those outlined in the National Mastitis Coun-
cil’s “5-point” plan (NMC, 2011), later extended to a 
“10-point” plan. Control programs have been quite suc-
cessful in reducing infectious mastitis, and in particular 
in decreasing the prevalence of Strep. agalactiae. How-
ever, their success in controlling S. aureus mastitis has 
been more variable (Ruegg, 2017). The precise reason 
for this is unknown, but S. aureus can be irregularly 
shed in milk, can form walled-off infections, and has a 
low cure rate after anti-microbial therapy (Sears et al., 
1990; Sol et al., 1997). The ability of S. aureus to act 
as a contagious or environmental pathogen with bovine 
and environmental reservoirs may also contribute to 
difficulties in controlling this pathogen (Sommerhauser 
et al., 2003; Klaas and Zadoks, 2018).
Mastitis control in dairy herds has traditionally in-
volved the treatment of clinical cases with antimicrobial 
agents, with blanket use of antibiotic dry cow therapy 
at the end of lactation also commonly practiced (Fran-
coz et al., 2016). Given societal concern regarding the 
use of antimicrobials in veterinary medicine, alterna-
tive strategies to prevent and manage bovine IMI are 
urgently required (Thanner et al., 2016). The purpose 
of this review is to highlight advances in our knowledge 
and understanding of pathogen and strain-specific IMI 
for the major pathogens S. aureus, Strep uberis, and 
E. coli and to share recent insights on the role of the 
pathogen strain in influencing the host response and 
disease progression.
PATHOGEN-ASSOCIATED HOST  
IMMUNE RESPONSE
The outcome of any IMI is dependent on several host 
factors including nutritional status, immune status, 
genetic makeup, parity, and stage of lactation (Rupp 
and Boichard, 2003; Hertl et al., 2011; Elghafghuf et 
al., 2014). Despite the extensive influence of the host 
on the progression and outcome of IMI, pathogen-
specific factors also play an important role in the 
pathophysiology of infection. The immune response can 
vary depending on both the species of the infecting 
bacterium and the strain of the infecting agent. The 
immune response to the major IMI pathogen species 
S. aureus, Strep uberis, and E. coli has recently been 
reviewed (Schukken et al., 2011; Petzl et al., 2018), 
whereas strain-associated differences are detailed be-
low. Innate immunity is a key component in the rec-
ognition and initiation of an immune response to IMI. 
Pathogen-associated molecular patterns (PAMP), 
conserved bacterial structures, are recognized by their 
cognate pattern recognition receptors expressed on the 
mammalian cell surface or within host cells. This insti-
gates a signaling cascade that ultimately results in the 
activation of the transcription factor complex NF-κB 
and the induction of pro-inflammatory cytokines and 
chemokines (Akira and Takeda, 2004), resulting in the 
influx and activation of immune cells in the mammary 
gland. Resident mammary epithelial cells (MEC) are 
proposed to be key primary actors in the initiation of a 
species-associated response (Wellnitz and Bruckmaier, 
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2012; Bauer et al., 2015; Gunther et al., 2016b). It has 
been reported that experimental infection of first lacta-
tion cows with E. coli resulted in a large increase in 
mammary gland expression of TNFα, IL8, IL10, and 
IL12 by 24 h postinfection, whereas no such increase 
was evident in S. aureus infected glands (Yang et al., 
2008). Infection of primary bovine MEC (pbMEC) 
in vitro with heat-killed E. coli results in activation 
of TLR4, subsequent NF-κB activation, and a large 
increase in expression of TNFα and the chemokine IL8. 
In contrast, infection of pbMEC with heat-killed S. au-
reus fails to activate NF-κB and results in induction of 
pro-inflammatory cytokines to a much lower level than 
that induced by E. coli (Yang et al., 2008; Gunther 
et al., 2016b). The major PAMP of E. coli, LPS, is 
a potent stimulator of TLR4, and interaction of LPS 
with TLR4 and its co-receptor CD14 at the surface of 
MEC and milk somatic cells, particularly macrophages, 
alerts the host immune system to the presence of an 
infecting microbe (Wang et al., 2002). The chemokine 
IL-8 promotes the recruitment of neutrophils, potent 
phagocytic leukocytes, to the udder, and protection 
from infection is dependent on the rapid recruitment 
of neutrophils and subsequent phagocytosis of invading 
microorganisms (Paape et al., 2002). However, it has 
been demonstrated that S. aureus, Strep. uberis, and E. 
coli each have the ability to invade and persist within 
bMEC, representing a niche where the organisms may 
evade phagocytosis (Matthews et al., 1994; Hebert 
et al., 2000; Dopfer et al., 2001). Differences between 
strains in ability to resist phagocytosis by bovine PMN 
in vitro have also been demonstrated, which may facili-
tate persistence of the organism in the mammary gland 
(Leigh et al., 1990; Leigh and Field, 1991; Aarestrup 
et al., 1994; Mullarky et al., 2001; Blum et al., 2008; 
Roussel et al., 2017). Pathogen-associated variation in 
the intramammary immune response is evident in the 
first hours after infection as E. coli immediately acti-
vates expression of pro-inflammatory genes, whereas S. 
aureus infection results in a slower response of lower 
magnitude (Yang et al., 2008; Petzl et al., 2016). It has 
been hypothesized that failure of S. aureus to activate 
NF-κB in MEC contributes to the diminished immune 
response observed in cows challenged with S. aureus 
compared with those challenged with E. coli (Rio-
llet et al., 2000; Bannerman et al., 2004b; Lee et al., 
2006; Yang et al., 2008). Although much initial work 
on the species-associated immune response focused on 
S. aureus and E. coli, it was subsequently shown that 
infection of isolated pbMEC with Strep. uberis also fails 
to activate NF-κB and subsequent induction of pro-in-
flammatory cytokines (Gunther et al., 2016a). Studies 
using a macrophage cell line have suggested that this 
cell type responds to all 3 major IMI pathogen species 
by activation of NF-κB and strong induction of immune 
gene expression (Gunther et al., 2016b). Much of the 
research to date has focused on the in vitro response of 
the different cell types to challenge with the major IMI 
pathogens. The differential induction of host immunity 
and the local and systemic responses observed postin-
fection are likely due to the combined response of both 
resident and recruited cells and the cross-talk between 
them. Future research should focus on understanding 
the interaction between the major cell types important 
in generating an immune response in vivo.
GENOMICS OF IMI PATHOGENS
Within each of the major bovine IMI pathogen spe-
cies, a diversity of strains and lineages (see Table 1) 
exists, each with a potentially unique repertoire of viru-
lence factors and immune-stimulatory antigens (Budd 
et al., 2015; Hossain et al., 2015; Keane, 2016). Strain 
typing of E. coli, Strep. uberis, and S. aureus isolates 
recovered from IMI has relied on several well-character-
ized methods including pulsed-field gel electrophoresis 
(PFGE), ribotyping, and multilocus sequence typ-
ing (MLST) to provide insights into their molecular 
epidemiology. Each method has its advantages and 
disadvantages; PFGE, which compares banding pat-
terns after restriction digestion of bacterial genomic 
DNA, has a high discriminatory power but is difficult 
to standardize across laboratories making comparisons 
across studies difficult. Multilocus sequence typing is 
a reproducible typing method based on the sequence 
of multiple house-keeping loci, with each unique se-
quence an allele. As MLST is based on allele rather 
than sequence comparison, it takes account of the fact 
that allele substitution by horizontal gene transfer will 
introduce many more polymorphisms than point muta-
tion (Maiden et al., 2013). Multilocus sequence typing 
allows inference about the population structure and 
evolutionary history of the isolates, although it is less 
discriminatory than PFGE (Grundmann et al., 2002; 
Ikawaty et al., 2009; Adkins et al., 2016). The avail-
ability of online MLST databases for several microbial 
pathogens, including S. aureus, Strep uberis, and E. 
coli, facilitates data sharing. The association between 
the various genotyping methods ranges between good 
agreement to poor agreement (Boss et al., 2016), and 
the choice of typing method may depend on the popula-
tion structure of the pathogen in question. Staphylo-
coccus aureus has a predominantly clonal population 
structure with infrequent recombination among strains, 
whereas recombination is more common in E. coli and 
particularly in Strep. uberis (Zadoks et al., 2005a; Cof-
fey et al., 2006; Wirth et al., 2006; Smyth et al., 2009). 
Specific bovine-adapted lineages of Strep. uberis and 
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E. coli have not been identified although an associa-
tion between bacterial lineage and disease status has 
been reported for Strep. uberis, with CC5 associated 
with clinical disease, ST143 with subclinical disease, 
and ST86 with latent infection (Tomita et al., 2008). In 
contrast, for S. aureus distinct lineages are associated 
with bovine infection, although the prevalence of the 
different lineages may vary geographically (Smyth et 
al., 2009; Budd et al., 2015). Each lineage has evolved 
relatively independently with only infrequent horizontal 
gene transfer between lineages (Waldron and Lindsay, 
2006). The genome of S. aureus consists of core genes, 
found in every isolate, and variable genes that can be 
present or absent depending on the strain. Many of 
the S. aureus virulence factors are encoded by variable 
genes, and carriage of these genes is often conserved 
within isolates of a given lineage (Lindsay, 2010; Budd 
et al., 2015). Therefore identifying the lineage of the 
infecting strain of S. aureus can also characterize the 
strain with respect to virulence factors.
Traditional strain-typing methods are fast being re-
placed by typing by whole-genome sequencing (WGS; 
Schurch et al., 2018). Next-generation sequencing 
greatly increases discriminatory power, thereby allow-
ing closely related strains to be distinguished. Impor-
tantly, it also enables rapid identification of emerging 
strains. Whole-genome MLST increases the number 
of alleles typed while maintaining back-compatibility 
with traditional MLST (Maiden et al., 2013). It fur-
ther allows identification of antimicrobial resistance 
and virulence genes. Identification of the most preva-
lent IMI strains, using a technique such as WGS or 
whole-genome MLST, which is unambiguous and eas-
ily comparable across laboratories, will facilitate the 
identification of globally distributed strains or lineages. 
It will also allow systematic review and meta-analysis 
of studies examining the association between strain or 
lineage and infection characteristics such as infection 
severity, infection duration, transmission, and cure 
rate after antimicrobial therapy. Comparative genom-
ics with strains isolated from humans or other animals 
may also lead to the identification of loci important 
for pathogenicity in each specific host, an approach 
that has already shown much promise (Lowder et al., 
2009; Guinane et al., 2010; Blum et al., 2018). The cost 
and labor requirements of WGS means this technique 
is likely to remain a research tool in the short term. 
However, comparative genomics of large numbers of 
IMI-associated strains could identify common genomic 
features of the predominant strains and lineages fa-
cilitating the development of fast, cheap, and accurate 
strain-typing methods that could be used in a clinical 
diagnostic setting.
BACTERIAL STRAIN INFLUENCES THE HOST 
IMMUNE RESPONSE
E. coli
Within each of the major mastitis-associated patho-
gen species, a variety of strains have been associated 
with disease or with different courses of disease. Al-
though many E. coli IMI are transient infections of 
short duration, persistent E. coli IMI, characterized by 
repeated episodes of clinical mastitis interspersed by 
periods of subclinical infection, can also be observed 
(Dopfer et al., 1999; Bradley and Green, 2001). The 
existence of genetically distinct strains of E. coli re-
sponsible for persistent and transient mastitis has 
been postulated (Dogan et al., 2012; Kerro Dego et 
al., 2012). Evidence for phenotypic differences between 
strains isolated from persistent and transient mastitis 
was provided when it was shown that strains of E. coli 
associated with persistent infection invaded, survived, 
and replicated in bMEC more highly than those associ-
ated with transient infection (Dogan et al., 2006). It 
was additionally shown that persistent IMI-associated 
and transient IMI-associated strains used different 
pathways for internalizing within bMEC (Passey et al., 
2008; Almeida et al., 2011). Despite these phenotypic 
differences, isolates from persistent and transient IMI 
are genetically diverse with no individual gene found 
to be more prevalent in either group, suggesting they 
evolved on multiple occasions from various commensal 
ancestors (Dogan et al., 2012; Richards et al., 2015).
For many years it was believed that the host immune 
response to E. coli IMI was driven by the conserved 
PAMP LPS and the infecting strain of E. coli had little 
or no influence on the host immune response to IMI 
(Burvenich et al., 2003). This view was supported by 
Table 1. Definitions of terms
Term  Definition
Isolate  A pure culture of bacteria derived from a single organism.
Strain  Similar isolates that can be distinguished from other isolates of the same species by phenotypic or genotypic methods.
Lineage  A group of genetically related strains derived from a recent common ancestor. The rate of diversification depends on the 
extent of recombination.
Host-adapted  Infects, persists, and transmits within a specific host species.
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studies that demonstrated that signs and symptoms of 
E. coli IMI were more homogeneous than those observed 
after S. aureus challenge (Petzl et al., 2008). However, 
although infection of pbMEC with strains of E. coli 
associated with either persistent or transient mastitis 
was reported to result in the upregulation of a large 
number of common genes, each strain type also had 
a unique gene expression signature. Infection with a 
strain isolated from a case of acute mastitis resulted in 
upregulation of immune response genes compared with 
infection with a strain isolated from a case of persistent 
mastitis, reflecting the higher level of inflammation in 
the acute case (Kerro Dego et al., 2012). More recently 
it has also been shown that the bovine immune response 
to intramammary challenge with 4 distinct strains of 
E. coli varied according to the infecting strain (Blum 
et al., 2017). The strains were isolated from various 
sources (acute mastitis, persistent mastitis, or the cow 
environment). Infection with strains VL2874 (acute 
mastitis) and VL2732 (persistent mastitis) resulted in 
the greatest increase in SCC and decrease in milk yield, 
whereas infection with strain P4 (acute mastitis) also 
resulted in increased SCC and decreased milk yield but 
the infection was resolved in 7 d. In comparison, E. 
coli strain K71 (cow environment) failed to establish an 
infection in the mammary gland and did not elicit any 
detectable immune or inflammatory response. Signifi-
cant differences were also present between the strains 
in their ability to induce expression of several secreted 
cytokines in milk (Blum et al., 2017).
Several studies have examined E. coli isolates for 
evidence of a specific subset of mammary-pathogenic 
E. coli (MPEC) with sometimes conflicting results. A 
variety of E. coli phylogroups have been associated with 
IMI and in some studies particular phylogroups or phy-
logenetic lineages were more commonly associated with 
mastitis, whereas in others no association was found 
(Blum et al., 2008; Blum and Leitner, 2013; Keane, 
2016; Leimbach et al., 2017). However, limitations of 
the strain-typing methods used may have contributed 
to the failure to detect MPEC as a recent whole-ge-
nome comparison of 66 phylogroup A mammary-de-
rived E. coli with phylogroup A dairy farm-derived E. 
coli found that mammary isolates had a reduction in 
phylogenetic diversity and a larger core genome but 
smaller pangenome than dairy farm isolates (Goldstone 
et al., 2016). Nineteen genes clustered in 3 loci were 
identified that were proposed to be essential for MPEC 
including the fecIRABCDE genes encoding the iron 
dicitrate utilization pathway. The genes fecABCDE 
form an operon composed of structural genes encoding 
for the outer membrane siderophore receptor (FecA) 
and a transport system (FecBCDE), whereas fecI and 
fecR encode ferric-citrate transport regulator proteins. 
Genes belonging to this locus were found in 100% of the 
MPEC isolates but only 68% of the other phylogroup A 
genomes (Goldstone et al., 2016). The protein products 
of this locus allow the bacteria to capture iron from 
ferric citrate and were subsequently demonstrated to 
facilitate growth of E. coli in milk. They were addition-
ally shown to be required for E. coli to cause IMI as 
deletion of the fec genes rendered the MPEC strain 
P4 nonpathogenic, whereas their introduction into the 
nonpathogenic strain K71 rendered this strain capable 
of causing IMI (Blum et al., 2018).
Strep. uberis
Streptococcus uberis is an IMI pathogen with reser-
voirs in the cow’s environment such as soil, bedding 
material, bovine body sites, and fecal matter (Zadoks 
et al., 2005b). Initial studies on the epidemiology of 
Strep. uberis IMI demonstrated a wide variety of geno-
types (Jayarao et al., 1993; Oliver et al., 1998; Phuektes 
et al., 2001). It was further reported that similar strains 
were recovered from environmental sources as from 
IMI, consistent with an environmental mode of trans-
mission (Zadoks et al., 2005b). However, despite the 
importance of environmental sources in the transmis-
sion of infection, it has also been demonstrated that, in 
some instances, within-cow or cow-to-cow transmission 
of Strep. uberis may occur (Phuektes et al., 2001; Zad-
oks et al., 2001; Tomita et al., 2008). Persistent Strep. 
uberis infection has additionally been documented, with 
the same strain recovered from the mammary gland of 
some cows from one lactation to the next (Oliver et al., 
1998).
Early evidence for strain-associated virulence of Strep. 
uberis was provided by Hill (1988) who demonstrated 
that strain 0140J reliably induced clinical mastitis after 
intramammary infusion and was resistant to killing in 
vitro by PMN, whereas strain EF20 only rarely induced 
clinical mastitis after intramammary infusion and was 
killed by PMN in vitro (Hill, 1988). However, the as-
sociation between ability to induce clinical mastitis 
and resisting killing by PMN was not replicated in 
a separate study using different strains (Tassi et al., 
2015). Although the same strains of Strep. uberis are 
frequently associated with both clinical and subclinical 
mastitis, there have been reports of particular strains 
of Strep. uberis more commonly associated with clini-
cal mastitis, further suggesting strain-specific virulence 
(Jayarao et al., 1993; Phuektes et al., 2001; Zadoks 
et al., 2003). The duration of Strep. uberis IMI has 
also been reported to be strain-dependent, with some 
strains causing infections of significantly longer dura-
tion than others (Zadoks et al., 2003). Streptococcus 
uberis has been reported to persist for extended periods 
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of time within bMEC without loss of host cell viability 
and strains also appear to vary in their invasiveness 
(Matthews et al., 1994; Tamilselvam et al., 2006).
The host immune response to Strep. uberis IMI has 
been proposed to vary according to the infecting strain. 
Infection of pbMEC with 2 different strains of Strep. 
uberis had different effects on the induction of immune 
response genes as determined by quantitative reverse-
transcription PCR (Swanson et al., 2009). Infection of 
pbMEC with strain 233 had no effect on immune gene 
expression, whereas infection with strain 266, a hyal-
uronic acid encapsulated strain isolated from a case of 
clinical mastitis, induced expression of C3, IL1β, and 
SAA3. An immune response particular to the infecting 
Strep. uberis strain was further demonstrated by Well-
nitz et al. (2012) who examined in vitro the response 
of pbMEC and milk somatic cells to a strain of Strep. 
uberis associated with persistent mastitis compared 
with a strain associated with acute mastitis. The strain 
isolated from acute mastitis caused a greater increase in 
expression of certain pro-inflammatory cytokines (IL8, 
IL1β) potentially reflecting the more severe inflamma-
tion associated with this strain (Wellnitz et al., 2012). 
Contrary to these reports, Gunther et al. (2016a) re-
ported no difference between heat-killed preparations 
of 7 strains of Strep. uberis in their ability to induce 
immune gene expression in pbMEC, and this cell type 
was found to fail to activate TLR signaling or NF-κB 
activation after Strep. uberis challenge (Gunther et al., 
2016a). In contrast they reported that RAW267.4 cells, 
a murine macrophage cell line, upregulated immune 
gene expression in response to Strep. uberis infection, 
albeit in a strain-independent manner (Gunther et al., 
2016a). However, they used only heat-killed prepara-
tions of Strep. uberis when investigating the immune 
response, which may not have fully reflected the vari-
ability between strains.
The in vivo host response to a strain of Strep. uberis 
associated with persistent infection was compared with 
the response to a strain associated with transient in-
fection. Intramammary infusion of the persistent IMI-
associated strain led to clinical mastitis, decreased milk 
yield, elevated SCC, and increased expression of pro-
inflammatory cytokines in milk. In contrast, infusion 
of the strain associated with transient mastitis failed to 
induce any clinical signs and bacteria were eliminated 
from the mammary gland by 3 d postinfection (Tassi 
et al., 2013). The strain from a case of persistent mas-
titis was more resistant to killing by macrophages but 
less resistant to killing by PMN than the strain from 
transient mastitis. The persistent IMI-associated strain 
also formed a weaker biofilm and was better able to 
adhere to bMEC, although it did not internalize more 
efficiently. The authors therefore suggested that ability 
to adhere to bMEC and to resist killing by milk mac-
rophages may be key virulence factors for Strep. uberis 
(Tassi et al., 2015).
The molecular mechanism underpinning the relation-
ship between the infecting strain and the pathophysiol-
ogy of Strep. uberis IMI has proven difficult to elucidate. 
Despite the differences between strain 0140J and EF20 
in ability to induce IMI, whole-genome analysis of these 
strains, along with other strains associated with clinical 
and subclinical infection, failed to illuminate an obvious 
genetic reason for this difference (Hossain et al., 2015). 
Further research is required to reveal the virulence fac-
tors necessary for Strep. uberis to cause bovine IMI and 
the basis of the observed strain-specific virulence.
S. aureus
Staphylococcus aureus has a highly clonal population 
structure and it is well known that particular lineages 
have adapted to infect a bovine host (Smyth et al., 
2009; Budd et al., 2015). These lineages include the 
pandemic bovine-adapted lineages CC97 and CC151 
(also known as CC705) as well as CC8, CC479, and 
CC133. Each lineage carries a particular variable ge-
nome characteristic of that lineage, and differences 
between lineages in geographical distribution and viru-
lence attributes have been reported (Zbinden et al., 
2014; Budd et al., 2016; Cosandey et al., 2016). Despite 
the limited number of lineages that predominate among 
bovine-adapted S. aureus, there is nonetheless consid-
erable strain diversity. Early studies on the molecular 
epidemiology of S. aureus IMI differed on whether the 
strain influenced disease presentation. Whereas some 
studies found that the infecting S. aureus strain had no 
bearing on IMI indicators such as SCC and N-acetyl-
β-d-glucosaminidase activity (Middleton et al., 2002), 
others reported that the severity of disease was related 
to the strain (Zadoks et al., 2000; Haveri et al., 2005). 
Additionally, particular genotypes, most notably geno-
type B (which predominantly consists of strains belong-
ing to CC8), have been reported to be associated with 
contagious mastitis with a high within-herd prevalence 
(Graber et al., 2009). It has also been reported that 
the inoculum required to induce IMI varies depending 
on the S. aureus strain. Whereas 10,000 cfu is required 
to reliably induce IMI with strain 1027 (CC133; Petzl 
et al., 2008), an inoculum of <100 cfu is sufficient for 
strain Newbould 305 (CC97; Bannerman et al., 2004b; 
Kauf et al., 2007; Bannerman et al., 2008).
Considerable evidence also points to differences be-
tween strains and lineages in virulence traits. Adher-
ence to epithelial cells has been proposed to play a 
role in the pathogenesis of S. aureus and to prevent 
the removal of the bacteria by milk flow. Subsequent 
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epithelial cell invasion by receptor-mediated endocy-
tosis may contribute to the persistence of S. aureus 
IMI and the failure of antibiotic therapy to clear S. 
aureus from the infected mammary gland. Differences 
between strains of S. aureus in their ability to adhere 
to and invade pbMEC have been reported (Hensen 
et al., 2000). Strains belonging to CC151 lack several 
well-characterized S. aureus surface proteins known to 
mediate interaction with host cells, either directly or 
via extracellular matrix proteins (Herron-Olson et al., 
2007; Budd et al., 2015) and strains from this lineage 
show reduced adherence to bMEC compared with 
strains from other lineages (Zbinden et al., 2014). Per-
sistent infection has also been proposed to be related 
to the ability of S. aureus to form small colony variants 
(SCV) that can survive within host cells with minimal 
deleterious effects (Atalla et al., 2008). Challenging 
cows with a parental strain and its SCV demonstrated 
that the SCV elicited a milder form of mastitis char-
acterized by a lower SCC and a delay in mounting an 
SCC response. The authors ascribed the ability of the 
SCV to induce a mild IMI to the reduced growth rate of 
the bacterium in combination with reduced production 
of α-toxin (Atalla et al., 2009). Antimicrobial suscep-
tibility has also been reported to be associated with S. 
aureus lineage (Sakwinska et al., 2011; Moser et al., 
2013; Budd et al., 2015).
The ability of the infecting strain of S. aureus to 
modulate the host immune response was reported by 
Zecconi et al. (2005) who found that infection with iso-
lates of particular genotypes was associated with a lower 
SCC response (Zecconi et al., 2005). A potential mo-
lecular mechanism underpinning this strain-dependent 
effect on SCC was provided by Lahouassa et al. (2007) 
who infected pbMEC with 3 strains of S. aureus and 
demonstrated differences between the strains in their 
ability to induce host cells to upregulate transcription 
of the pro-inflammatory cytokines IL1β, TNFα, and 
IL8 and to produce chemoattractant factors capable of 
polarizing neutrophils (Lahouassa et al., 2007). How-
ever, the strains used in this study were not typed. 
More recently, the ability of strains of defined lineages 
to induce a pro-inflammatory response from bMEC 
has been characterized. It was found that infection of 
bMEC with strains of S. aureus belonging to CC151 
resulted in lower pro-inflammatory gene and protein 
expression in addition to a longer lag time before gene 
expression was induced compared with strains from 
other bovine-adapted lineages (Budd et al., 2016). The 
CC151 strains were further demonstrated to fail to in-
duce the production of chemoattractants from bMEC. 
Conditioned media from bMEC infected with strains 
belonging to CC97 strongly attracted bovine neutro-
phils, whereas conditioned media from bMEC infected 
with strains belonging to CC151 failed to result in neu-
trophil chemotaxis (unpublished data). The failure of 
strains belonging to CC151 to stimulate bMEC was also 
observed by Zbinden et al., who reported that infection 
of bMEC with strains of CC151 induced lower levels 
of pro-inflammatory cytokine production than strains 
of other bovine-adapted lineages (CC8, CC97, CC20; 
Zbinden et al., 2014). They hypothesized that this 
would result in strains belonging to CC151 being less 
virulent than other bovine-adapted strains. However, 
a prompt response to an infecting pathogen has been 
shown to be crucial for controlling IMI and preventing 
invasive disease (Rainard and Riollet, 2003). Therefore, 
the failure of CC151 strains to elicit a robust immune 
response and production of chemotactic factors from 
bMEC may lead to a later or weaker attraction (or 
both) of leukocytes to the mammary gland, allowing 
strains from this lineage time to be established in the 
mammary gland. Interestingly, experimental infection 
of cows with CC151 S. aureus strains has demonstrated 
the propensity for strains from this lineage to cause 
clinical mastitis (Keane et al., 2018; Wilson et al., 
2018).
Attempts to identify a set of genes necessary for 
S. aureus to cause IMI have so far not been success-
ful and few genes that are unique to bovine-adapted 
strains have been identified (Kozytska et al., 2010). 
The ruminant-specific leukotoxin lukM/lukF ′ has been 
hypothesized to be a major virulence factor as it con-
fers on S. aureus the ability to lyse migrating neutro-
phil effector cells at a distance (Monecke et al., 2007; 
Hata et al., 2010; Vrieling et al., 2015). The lukMF ′ 
genes are highly prevalent among strains belonging 
to CC151, CC479, and CC133 but uncommon among 
other bovine-adapted lineages (Schlotter et al., 2012; 
Budd et al., 2015). Among strains that encode lukM/
lukF, production of functional leukotoxin also varies. 
Deletion of lukMF ′ has been shown to result in a failure 
of S. aureus to kill bovine neutrophils (Vrieling et al., 
2015). Intramammary challenge of cows with S. aureus 
strain S1444, which produces high levels of LukMF ′, re-
sulted in more severe clinical signs than challenge with 
strains S1449 and S1463, which produce intermediate 
levels of LukMF ′, although SCC was similar between 
the groups (Vrieling et al., 2016). However, S1444 be-
longs to CC479 (Hoekstra et al., 2018), whereas the 
lineage to which S1449 and S1463 belong was not re-
ported. Therefore, the strains may vary in more than 
just production of LukMF ′ and challenge of cows with 
strain S1444 lacking lukMF ′ would confirm the role of 
this toxin in virulence of bovine-adapted S. aureus.
Although cow factors are undoubtedly important in 
determining the response to IMI, species and strain-
dependent variation in immune response, mastitis indi-
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cators such as SCC, and infection severity and outcome 
has been demonstrated for S. aureus, Strep. uberis, and 
E. coli (de Haas et al., 2004; Yang et al., 2008; Atalla 
et al., 2009; Tassi et al., 2013; Blum et al., 2017; Keane 
et al., 2018). Several virulence traits have been hypoth-
esized to underpin this variation including differences 
in ability to invade and survive within epithelial cells 
and professional phagocytes and survive neutrophil 
killing (Dogan et al., 2006; Tassi et al., 2015; Budd et 
al., 2016). However, much of the evidence supporting 
these hypotheses comes from in vitro studies. Bacterial 
gene expression is tightly regulated in vivo and further 
work is required to determine the importance of these 
traits in the intramammary environment. Deep tran-
scriptome and proteome analysis of mammary gland 
tissue and different immune cell types will enable the 
unbiased identification of bovine and bacterial genes 
and proteins expressed in vivo, even those expressed 
at low levels. Interaction proteomics can be applied 
to identify the range of bacterial adhesins capable of 
interacting with bovine cells, along with their cognate 
receptors, contributing to the identification of novel di-
agnostic markers and vaccine and therapeutic targets.
VACCINES
Of the major IMI pathogen species, vaccines de-
veloped against E. coli have arguably been the most 
successful and are generally based on the bacterins of 
strains such as J5. Such vaccines do not provide com-
plete protection against E. coli IMI but rather result in 
increased levels of specific IgG1 and IgG2 antibodies 
and a reduction in the severity of clinical signs and in 
milk loss. Importantly, protection against heterologous 
strains of E. coli is also observed (Hogan et al., 1992a,b, 
1995). More recent studies have focused on intramam-
mary vaccination against E. coli and demonstrated that 
local immunization resulted in reduced inflammation 
and conferred superior protection to intramuscular vac-
cination and that this was due to a modification of the 
local cytokine profile rather than an improved humoral 
adaptive immune response (Herry et al., 2017).
Vaccination using repeated intramammary inocula-
tion of whole killed Strep. uberis has been reported to 
protect against infection with the homologous strain, 
whereas subcutaneous vaccination resulted in partial 
protection. Vaccination resulted in an increase in spe-
cific IgG1, IgG2, and IgM, but there was no evidence 
for enhanced opsonic activity leading to increased 
phagocytic uptake (Finch et al., 1994). Subcutaneous 
vaccination of cows with live Strep. uberis combined 
with intramammary infusion of bacterial surface ex-
tract also afforded protection against the homologous 
strain; however, vaccination did not provide adequate 
protection against a heterologous strain (Finch et al., 
1997). The Strep. uberis proteins plasminogen activator 
PauA, the cell surface associated protein GapC, and 
Strep. uberis adhesion molecule SUAM have all been 
examined for their ability to provide protection against 
Strep. uberis mastitis (Leigh et al., 1999; Prado et al., 
2011; Song et al., 2017). However, it must be noted that 
while the prevalence of the gapC, sua, and pauA genes 
among bovine Strep. uberis isolates is high, heterogene-
ity in gene carriage and gene sequence has also been 
observed (Gilchrist et al., 2013; Perrig et al., 2015). 
Therefore, any vaccine based on these single proteins 
may only provide strain-specific protection and may 
confer a selective advantage to Strep. uberis strains 
that are not covered by the vaccine. A commercial 
subunit vaccine for S. uberis, UBAC, has been recently 
launched on the market. The precise composition is not 
described but it consists of a preparation of biofilm 
adhesion component and includes lipoteichoic acid. 
Challenge of vaccinated cows with a heterologous strain 
of Strep. uberis showed that vaccination did not prevent 
infection but reduced clinical mastitis signs, bacterial 
count in milk, and milk yield (Collado et al., 2018). 
This vaccine requires the administration of 3 doses yet 
does not induce long-lasting immunity (https: / / www 
.ema .europa .eu/ documents/ product -information/ ubac 
-epar -product -information _en .pdf). Further studies 
are required to assess the efficacy of this vaccine on 
commercial dairy farms under a variety of management 
systems and against a range of Strep. uberis strains.
The development of an effective vaccine against S. 
aureus has long been a research priority in both human 
and veterinary medicine. Societal concern regarding 
the use of antimicrobials in veterinary medicine and 
the potential spread of antimicrobial resistance deter-
minants to human-associated S. aureus has acted as 
a new impetus to vaccine research. However, infection 
with S. aureus does not result in the development of 
immunity to re-infection and the role of the adaptive 
immune system is poorly understood.
A wide variety of S. aureus virulence factors and 
surface proteins have been investigated for their ability 
to act as antigens, which could induce a protective im-
mune response against subsequent S. aureus challenge. 
Protein A, encoded by the spa gene, was one of the 
first cell wall anchored proteins of S. aureus to be char-
acterized and was an early target of vaccine research 
(Pankey et al., 1985). Well known for its ability to bind 
the Fc fragment of mammalian IgG (Moks et al., 1986), 
SpA has subsequently been found to bind other ligands 
including the Fab domain of VH3 immunoglobulins 
(Hillson et al., 1993), von Willebrand factor (Hartleib 
et al., 2000), and tumor necrosis factor receptor-1 
(Gomez et al., 2004). Noted for its polymorphism, spa 
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is also commonly exploited in epidemiological studies 
of S. aureus (Zecconi et al., 2005). By binding immu-
noglobulins in the incorrect orientation, SpA inhibits 
opsonization and subsequent phagocytosis and is a well 
characterized virulence factor of S. aureus (Haraldsson 
and Jonsson, 1984; Patel et al., 1987). However, results 
of vaccine trials with SpA have been equivocal. Vac-
cination of first lactation cows with SpA was reported 
to increase the spontaneous cure rate and decrease SCC 
after S. aureus challenge; however, it did not reduce 
the incidence of IMI (Pankey et al., 1985). In a mouse 
IMI model, vaccination with SpA reduced the bacterial 
load in the mammary gland but did not protect against 
tissue damage after S. aureus challenge (Gogoi-Tiwari 
et al., 2016). The suitability of SpA as a vaccine target 
was further called into question by the discovery that 
strains belonging to the globally distributed bovine-
adapted lineage CC151 do not express this protein on 
their cell surface (Stutz et al., 2011). In CC151 the spa 
gene is truncated, resulting in a protein product lack-
ing the C-terminal LPxTG motif, required for Sortase 
A-mediated anchoring of SpA to the cell wall (Herron-
Olson et al., 2007; Budd et al., 2016). Therefore, any 
vaccine based on protein A alone would not be expected 
to protect against mastitis caused by strains belonging 
to CC151.
The development of a vaccine based on surface 
expressed adhesins of S. aureus has also been widely 
pursued (Brouillette et al., 2002; Castagliuolo et al., 
2006; Pujato et al., 2018). Major vaccine targets have 
included MSCRAMM proteins (microbial surface com-
ponents recognizing adhesive matrix molecules) such as 
fibronectin-binding proteins FnBPA and FnBPB as well 
as clumping factor A (ClfA), and DNA-protein vacci-
nation against these adhesins has been demonstrated to 
provide some protection against bovine IMI (Shkreta et 
al., 2004). However, it has also been shown that while 
a DNA vaccine directed against 3 different adhesins, 
fibrinogen-binding protein (Ebf), FnBPA, and ClfA in-
duced significant levels of antigen-specific IgG and IgM 
in mice (Castagliuolo et al., 2006), the ability of the 
antibodies to recognize S. aureus was strain-dependent 
with several strains only poorly recognized (Scarpa 
et al., 2010). The carriage and expression of adhesins 
among bovine-adapted S. aureus is predominantly 
conserved within a lineage, although variation among 
strains of a lineage has also been reported (McCarthy 
and Lindsay, 2010; Budd et al., 2015). Of note, CC151 
lacks several well-characterized adhesins such as fnbB, 
cna, sasG, and sasK and does not appear to express 
FnBPA. Additionally, CC71 lacks sasD whereas CC97 
lacks cna. Therefore, any vaccine based on S. aureus 
adhesins would need to account for such variability and 
polymorphisms among bovine-adapted strains.
Currently 2 vaccines are marketed for the control of 
S. aureus IMI. These vaccines, Startvac and Lysigin, 
both contain whole inactivated S. aureus and require 
multiple administrations of the vaccine to confer short-
term protection. As both products fail to induce long-
term protective immunity, regular re-administration is 
required. Startvac, currently available in Europe and 
Canada, includes a bacterin based on S. aureus SP140, 
a strain which expresses the slime associated antigenic 
complex (SAAC) in addition to inactivated E. coli J5 
(Prenafeta et al., 2010). The critical parameters for 
evaluating this vaccine depend on whether the aim is to 
control contagious or environmental IMI. For a conta-
gious pathogen, limiting transmission is the goal and so 
a reduction in new infections or in the duration of infec-
tion is desirable. For environmental pathogens, a reduc-
tion in the severity of disease is the objective. There 
have been conflicting reports on the efficacy of this 
vaccine. Schukken et al. (2014) found that vaccination 
reduced the incidence of new S. aureus IMI in addition 
to reducing the duration, whereas Landin et al. (2015) 
reported that vaccination offered no protection against 
new S. aureus IMI and did not have any effect on SCC 
or milk yield. Bradley et al. (2015) found no difference 
in the proportion of cows with subclinical mastitis or 
in the incidence of IMI between vaccinated and unvac-
cinated cows, albeit they primarily evaluated the E. coli 
component of the vaccine as the study was carried out 
in herds where clinical IMI was predominantly due to E. 
coli. They did however report that vaccination resulted 
in increased milk yield and a reduction in the sever-
ity of clinical IMI (Bradley et al., 2015). It has been 
proposed that SAAC is the major S. aureus protective 
antigen of Startvac (Prenafeta et al., 2010). The SAAC 
primarily consists of the surface polysaccharide poly-N-
acetyl β-1,6 glucosamine (PNAG), the product of the 
intercellular adhesion (ica) operon. It must be noted, 
however, that production of biofilm/SAAC is highly 
variable among S. aureus strains and not all strains 
encode the ica operon necessary for the production of 
PNAG. Strains belonging to CC71 do not encode this 
operon due to a large genomic rearrangement near the 
origin of replication in this lineage (Budd et al., 2015) 
and so Startvac may not provide any protection against 
infection with strains from this lineage.
Despite extensive research the development of an 
effective S. aureus vaccine that confers long-term im-
munity is still elusive, and may be unrealistic given 
that long-term immunity does not arise after natural 
infections. Most staphylococcal vaccine research has 
focused on antigens that drive the development of an 
adaptive humoral immune response (Brouillette et al., 
2002; Shkreta et al., 2004; Prenafeta et al., 2010; Pujato 
et al., 2018), although S. aureus possesses a variety of 
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virulence factors that interfere with antibody function. 
A vaccine that drives both cell-mediated and humoral 
immune responses may confer additional protection. An 
improved understanding of the cell-mediated immune 
response and in particular the role of the various T 
cell subsets in regulating phagocyte effector functions 
and bacterial clearance would aid the development of 
the next generation of vaccines against S. aureus IMI. 
In the future the antigenic repertoire of the range of S. 
aureus lineages associated with bovine IMI should be 
considered, with the goal of developing a vaccine that 
protects against the major bovine-adapted S. aureus 
strains. Multiple variants of the antigenic targets may 
need to be included in any vaccine cocktail and vaccine 
trials should test for efficacy against the common S. 
aureus lineages.
CONCLUSIONS
An increased demand for milk and milk products has 
precipitated an expansion in dairy production across 
the world. In tandem the need to reduce our reliance on 
nonselective antibiotic use has brought a renewed focus 
on dairy production systems. Therefore, the impetus to 
develop new and sustainable strategies to manage and 
control infectious diseases such as IMI has never been 
greater. Intramammary infection is a multi-factorial 
disease influenced by a variety of factors related to the 
host, pathogen, and environment. Strategies to manage 
and control this disease will benefit from an improved 
understanding of these factors and how they interact. 
The host immune response, as determined by the extent 
of leukocyte recruitment to the mammary gland, is a key 
trait used for mastitis diagnosis and breeding for mas-
titis resistance. Understanding inter-strain variation in 
ability to elicit a host response will therefore facilitate 
tailored diagnosis and breeding strategies based on the 
species and strain of infecting pathogen. Additionally, 
the activation of an immune response is a key precursor 
to subsequent bacterial clearance from the mammary 
gland. Strains that cause chronic or persistent infection 
have developed means to evade immune detection, such 
as internalization into host cells. Identification of key 
mechanisms by which bacteria evade immune system 
detection will likely yield novel therapeutic and vaccine 
targets. This will require knowledge of the repertoire 
of bacterial lineages and strains that cause bovine IMI, 
their major virulence factors, and molecular mecha-
nisms of pathogenesis. Characterization of the diversity 
of strains associated with bovine IMI and how differ-
ent strains interact with the host will contribute to the 
development of new therapies and vaccines in addition 
to furthering our understanding of the factors required 
for the development of a protective immune response. 
Recent advances in the areas of pathogenomics, tran-
scriptomics, and proteomics provide us with the tools 
to deepen our understanding of host-pathogen inter-
actions and strain-specific interactions for IMI and to 
identify key mediators of these interactions.
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